Profile data is unavailable for this security.
About the company
Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.
- Revenue in USD (TTM)212.87m
- Net income in USD948.00k
- Incorporated1982
- Employees698.00
- LocationMesa Laboratories Inc12100 W 6th AveLAKEWOOD 80228-1252United StatesUSA
- Phone+1 (303) 987-8000
- Fax+1 (303) 987-8989
- Websitehttps://mesalabs.com
More ▼
Mergers & acquisitions
| Acquired company | MLAB:NSQ since announced | Transaction value |
|---|---|---|
| SAL Schiffahrtskontor Altes Land GmbH & Co KG | 11.75% | 89.33m |
| gke-GmbH-Sterilization Indicators Business | 11.75% | -- |
Data delayed at least 15 minutes, as of May 02 2024 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seer Inc | 16.66m | -86.28m | 137.32m | 147.00 | -- | 0.3434 | -- | 8.24 | -1.35 | -1.35 | 0.2609 | 6.17 | 0.0361 | 1.79 | 2.43 | 113,340.10 | -18.67 | -16.65 | -19.21 | -17.09 | 51.05 | -- | -517.84 | -756.71 | 24.66 | -- | 0.00 | -- | 7.54 | -- | 7.20 | -- | 112.67 | -- |
| Geospace Technologies Corp | 143.43m | 24.98m | 158.21m | 681.00 | 6.36 | 1.08 | 3.86 | 1.10 | 1.87 | 1.87 | 10.76 | 10.99 | 0.938 | 3.76 | 4.35 | 210,619.70 | 16.34 | -5.10 | 18.55 | -5.54 | 44.20 | 28.70 | 17.42 | -8.96 | 3.79 | -- | 0.00 | -- | 39.50 | 10.45 | 153.40 | -- | 11.01 | -- |
| Harvard Bioscience, Inc. | 112.25m | -3.42m | 165.87m | 391.00 | -- | 2.27 | 46.29 | 1.48 | -0.0803 | -0.0803 | 2.63 | 1.68 | 0.7941 | 1.81 | 6.84 | 287,084.40 | -2.42 | -3.29 | -2.93 | -3.89 | 58.86 | 56.67 | -3.04 | -4.57 | 0.9164 | 0.4485 | 0.3335 | -- | -0.9573 | -1.45 | 64.11 | -- | 18.10 | -- |
| Northern Technologies International Corp | 82.70m | 3.66m | 166.87m | 86.00 | 46.93 | 2.44 | 24.40 | 2.02 | 0.3772 | 0.3772 | 8.61 | 7.25 | 0.9537 | 3.76 | 5.27 | 961,669.60 | 5.88 | 6.29 | 7.44 | 7.71 | 37.01 | 33.21 | 6.16 | 7.42 | 1.86 | -- | 0.0524 | 53.37 | 7.75 | 9.21 | -53.95 | -16.87 | 34.39 | 13.30 |
| Virtra Inc | 38.04m | 8.40m | 178.53m | 112.00 | 21.00 | 4.19 | 19.13 | 4.69 | 0.7653 | 0.7653 | 3.47 | 3.84 | 0.6163 | 1.03 | 2.78 | 339,672.80 | 13.61 | 7.69 | 17.16 | 9.70 | 70.09 | 59.06 | 22.09 | 11.12 | 2.32 | -- | 0.1587 | -- | 34.42 | 16.04 | 329.62 | 59.34 | 30.96 | -- |
| 908 Devices Inc. | 50.23m | -36.40m | 186.93m | 230.00 | -- | 1.12 | -- | 3.72 | -1.13 | -1.13 | 1.56 | 5.09 | 0.2255 | 1.81 | 5.28 | 218,387.00 | -16.34 | -14.16 | -18.03 | -15.35 | 50.41 | 53.02 | -72.47 | -64.25 | 7.04 | -- | 0.00 | -- | 7.21 | 17.89 | -8.45 | -- | 22.98 | -- |
| FARO Technologies Inc | 358.83m | -56.58m | 358.33m | 1.24k | -- | 1.33 | -- | 0.9986 | -3.00 | -3.00 | 18.97 | 14.16 | 0.7338 | 4.58 | 3.94 | 288,681.40 | -11.57 | -7.48 | -14.92 | -9.49 | 45.98 | 51.08 | -15.77 | -10.70 | 2.00 | -10.20 | 0.2131 | -- | 3.78 | -2.33 | -111.46 | -- | 1.61 | -- |
| Mesa Laboratories Inc | 212.87m | 948.00k | 594.32m | 698.00 | 629.10 | 1.47 | 16.84 | 2.79 | 0.1751 | 0.1751 | 39.54 | 74.70 | 0.3031 | 2.38 | 5.43 | 304,977.10 | 0.135 | 0.6535 | 0.1438 | 0.7029 | 61.02 | 60.10 | 0.4453 | 1.97 | 1.86 | 0.2604 | 0.3663 | 100.96 | 18.85 | 17.90 | -50.29 | -- | 10.18 | 0.00 |
| Quanterix Corp | 122.37m | -32.33m | 630.69m | 441.00 | -- | 1.81 | -- | 5.15 | -0.8587 | -0.8587 | 3.26 | 9.13 | 0.2848 | 2.64 | 5.51 | 277,478.50 | -7.53 | -15.96 | -8.19 | -17.66 | 57.73 | 52.79 | -26.42 | -53.79 | 9.26 | -- | 0.00 | -- | 15.96 | 26.60 | 66.56 | -- | 20.07 | -- |
| Standard Biotools Inc | 106.34m | -74.66m | 962.31m | 534.00 | -- | -- | -- | 9.05 | -0.9437 | -0.9437 | 1.34 | 2.03 | 0.2981 | 2.66 | 5.76 | 199,138.60 | -20.93 | -28.17 | -26.63 | -33.60 | 47.44 | 51.58 | -70.21 | -74.85 | 1.26 | -13.80 | 0.2801 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
| CTS Corp | 550.42m | 60.53m | 1.46bn | 4.08k | 24.75 | 2.77 | 16.31 | 2.64 | 1.92 | 1.92 | 17.43 | 17.09 | 0.739 | 5.88 | 6.49 | 134,874.30 | 8.13 | 4.48 | 9.46 | 5.33 | 34.68 | 34.71 | 11.00 | 5.86 | 2.67 | -- | 0.1136 | 17.23 | -6.21 | 3.19 | 1.61 | 5.56 | -12.35 | 0.00 |
Data as of May 02 2024. Currency figures normalised to Mesa Laboratories Inc's reporting currency: US Dollar USD
56.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2023 | 751.75k | 13.94% |
| Conestoga Capital Advisors LLCas of 31 Mar 2024 | 580.74k | 10.77% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 356.15k | 6.60% |
| Royce & Associates LPas of 31 Dec 2023 | 269.65k | 5.00% |
| Ranger Investment Management LPas of 31 Dec 2023 | 226.68k | 4.20% |
| Atlanta Capital Management Co. LLCas of 31 Dec 2023 | 206.76k | 3.83% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 198.41k | 3.68% |
| Geneva Capital Management LLCas of 31 Dec 2023 | 189.53k | 3.51% |
| Dimensional Fund Advisors LPas of 31 Dec 2023 | 127.24k | 2.36% |
| Eagle Asset Management, Inc.as of 31 Dec 2023 | 115.28k | 2.14% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
